Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patients - Turpie, AG; Lensing, AW; Fuji, T; Boyle, DA (Blood Coagul Fibrinolysis, 2009)